Italia markets closed

BMY May 2024 45.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,0600-0,1200 (-10,17%)
Alla chiusura: 03:54PM EDT
Schermo intero
Chiusura precedente1,1800
Aperto1,1500
Denaro0,1900
Lettera3,1500
Prezzo d'esercizio45,00
Scadenza2024-05-03
Min-Max giorno0,8500 - 1,2500
Contratto - Min-MaxN/D
Volume70
Open Interest841
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri